The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Systemic Activation of the Transient Receptor Potential Vanilloid Subtype 4 Channel Causes Endothelial Failure and Circulatory Collapse: Part 2
Abstract
The transient receptor potential (TRP) vanilloid subtype 4 (V4) is a nonselective cation channel that exhibits polymodal activation and is expressed in the endothelium, where it contributes to intracellular Ca2+ homeostasis and regulation of cell volume. The purpose of the present study was to evaluate the systemic cardiovascular effects of GSK1016790A, a novel TRPV4 activator, and to examine its mechanism of action. In three species (mouse, rat, and dog), the i.v. administration of GSK1016790A induced a dose-dependent reduction in blood pressure, followed by profound circulatory collapse. In contrast, GSK1016790A had no acute cardiovascular effects in the TRPV4-/- null mouse. Hemodynamic analyses in the dog and rat demonstrate a profound reduction in cardiac output. However, GSK1016790A had no effect on rate or contractility in the isolated, buffer-perfused rat heart, and it produced potent endothelial-dependent relaxation of rodent-isolated vascular ring segments that were abolished by nitric-oxide synthase (NOS) inhibition (N-nitro-L-arginine methyl ester; L-NAME), ruthenium red, and endothelial NOS (eNOS) gene deletion. However, the in vivo circulatory collapse was not altered by NOS inhibition (L-NAME) or eNOS gene deletion but was associated with (concentration and time appropriate) profound vascular leakage and tissue hemorrhage in the lung, intestine, and kidney. TRPV4 immunoreactivity was localized in the endothelium and epithelium in the affected organs. GSK1016790A potently induced rapid electrophysiological and morphological changes (retraction/condensation) in cultured endothelial cells. In summary, inappropriate activation of TRPV4 produces acute circulatory collapse associated with endothelial activation/injury and failure of the pulmonary microvascular permeability barrier. It will be important to determine the role of TRPV4 in disorders associated with edema and microvascular congestion.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“HUVECs may not entirely recapitulate all known roles for TRPV4 in tumor vasculature. 24,28,35,51,53,66”
From Rapid Assessment of Nanoparticle Extravasation in a Microfluidic Tumor Model (2019) · cites this paper as [24]
Citations
Cites
Guide for the Care and Use of Laboratory Animals: Eighth Edition
(2011) · doi:10.17226/12910 · Cited by 16,199
Liedtke, W., Choe, Y., Martı́-Renom, M. A., Bell, A. M., Denis, C. S., AndrejŠali, Hudspeth, A. J., Friedman, J. M., & Heller, S. (2000) · Cell · doi:10.1016/s0092-8674(00)00143-4 · Cited by 1,391
Cellular regulation of endothelial nitric oxide synthase
Govers, R., & Rabelink, T. J. (2001) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2001.280.2.f193 · Cited by 476
TRPV4 Forms a Novel Ca 2+ Signaling Complex With Ryanodine Receptors and BK Ca Channels
Earley, S., Heppner, T. J., Nelson, M. T., & Brayden, J. E. (2005) · Circulation Research · doi:10.1161/01.res.0000194321.60300.d6 · Cited by 448
Yue, T., Wang, C., Gu, J.-L., Ma, X., Kumar, S., Lee, J. C., Feuerstein, G., Thomas, H. C., Maleeff, B. E., & Ohlstein, E. H. (2000) · Circulation Research · doi:10.1161/01.res.86.6.692 · Cited by 421
Self-citationTransient Receptor Potential Channels in Cardiovascular Function and Disease
Inoue, R., Jensen, L. J., Shi, J., Morita, H., Nishida, M., Honda, A., & Ito, Y. (2006) · Circulation Research · doi:10.1161/01.res.0000233356.10630.8a · Cited by 368
Köhler, R., Heyken, W., Heinau, P., Schubert, R., Si, H., Kacik, M., Busch, C., Grgic, I., Maier, T., & Hoyer, J. D. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000225698.36212.6a · Cited by 346
Transient Receptor Potential Vanilloid 4–Mediated Disruption of the Alveolar Septal Barrier
Alvarez, D. F., KING, J. A. C., Weber, D. S., Addison, E., Liedtke, W., & Townsley, M. I. (2006) · Circulation Research · doi:10.1161/01.res.0000247065.11756.19 · Cited by 311
Yang, X.-R., Lin, M., McIntosh, L. S., & Sham, J. S. K. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00515.2005 · Cited by 278
Self-citationRecent Developments in Vascular Endothelial Cell Transient Receptor Potential Channels
Yao, X., & Garland, C. J. (2005) · Circulation Research · doi:10.1161/01.res.0000187473.85419.3e · Cited by 276
Cited by
Sorted by citations
Elementary Ca 2+ Signals Through Endothelial TRPV4 Channels Regulate Vascular Function
Sonkusare, S. K., Bonev, A. D., Ledoux, J., Liedtke, W., Kotlikoff, M. I., Heppner, T. J., Hill-Eubanks, D. C., & Nelson, M. T. (2012) · Science · doi:10.1126/science.1216283 · Cited by 552
Transient receptor potential channels as therapeutic targets
Moran, M. M., McAlexander, M. A., Bı́ró, T., & SZALLASI, A. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3456 · Cited by 560
Nilius, B., & SZALLASI, A. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008268 · Cited by 510
TRPV4: molecular conductor of a diverse orchestra
White, J. P. M., Cibelli, M., Urban, L., Nilius, B., McGeown, J. G., & Nagy, I. (2016) · Physiological Reviews · doi:10.1152/physrev.00016.2015 · Cited by 405
Transient Receptor Potential Channels in the Vasculature
Earley, S., & Brayden, J. E. (2015) · Physiological Reviews · doi:10.1152/physrev.00026.2014 · Cited by 414
Pharmacology of Vanilloid Transient Receptor Potential Cation Channels
Vriens, J., Appendino, G., & Nilius, B. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.055624 · Cited by 416
Everaerts, W., Zhen, X.-G., Ghosh, D., Vriens, J., Gevaert, T., Gilbert, J. P., Hayward, N. J., McNamara, C. R., Xue, F., Moran, M. M., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005333107 · Cited by 417
Thorneloe, K. S., Sulpizio, A. C., Lin, Z., Figueroa, D. J., Clouse, A. K., McCafferty, G. P., Chendrimada, T. P., Lashinger, E. S. R., Gordon, E., Evans, L. C., et al. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.139295 · Cited by 413
Self-citationTransient receptor potential ( TRP ) channels: a clinical perspective
Kaneko, Y., & SZALLASI, A. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12414 · Cited by 383
The vanilloid transient receptor potential channel TRPV4: From structure to disease
Everaerts, W., Nilius, B., & Owsianik, G. (2009) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2009.10.002 · Cited by 347
TRPV4 Is a Regulator of Adipose Oxidative Metabolism, Inflammation, and Energy Homeostasis
Li, Y., Kleiner, S., Wu, J., Sah, R., Gupta, R. K., Banks, A. S., Cohen, P., Khandekar, M. J., Boström, P., Mepani, R. J., et al. (2012) · Cell · doi:10.1016/j.cell.2012.08.034 · Cited by 353
TRPV4-mediated endothelial Ca2+ influx and vasodilation in response to shear stress
Mendoza, S. A., Fang, J., Gutterman, D. D., Wilcox, D. A., Bubolz, A. H., Li, R., Suzuki, M., & Zhang, D. X. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00854.2009 · Cited by 342
Thorneloe, K. S., Cheung, M., Bao, W., Alsaid, H., Lenhard, S., Jian, M.-Y., Costell, M., Maniscalco-Hauk, K., Krawiec, J. A., Olzinski, A., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004276 · Cited by 337
Self-citationFélétou, M., & Vanhoutte, P. M. (2009) · Clinical Science · doi:10.1042/cs20090096 · Cited by 331
Calcium‐activated potassium channels and endothelial dysfunction: therapeutic options?
Félétou, M. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00052.x · Cited by 244
Sulk, M., Seeliger, S., Aubert, J., Schwab, V. D., Cevikbas, F., Rivier, M., Nowak, P., Voegel, J. J., Buddenkotte, J., & Steinhoff, M. S. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.424 · Cited by 234
TRPV4-dependent dilation of peripheral resistance arteries influences arterial pressure
Earley, S., Pauyo, T., Drapp, R., Tavares, M. J., Liedtke, W., & Brayden, J. E. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00241.2009 · Cited by 232
Ryskamp, D. A., Witkovsky, P., Barabás, P., Huang, W. C., Koehler, C. L., Akimov, N. P., Lee, S. H., Chauhan, S., Xing, W., Renterı́a, R. C., et al. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.0359-11.2011 · Cited by 228
TRP Channels as Potential Drug Targets
Moran, M. M. (2017) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010617-052832 · Cited by 218
Balakrishna, S., Song, W., Achanta, S., Doran, S. F., Liu, B., Kaelberer, M. M., Yu, Z., Sui, A., Cheung, M., Leishman, E., et al. (2014) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00065.2014 · Cited by 206
Self-citationTRPV channels and vascular function
Baylie, R. L., & Brayden, J. E. (2010) · Acta Physiologica · doi:10.1111/j.1748-1716.2010.02217.x · Cited by 203
Félétou, M. (2011) · Colloquium Series on Integrated Systems Physiology From Molecule to Function · doi:10.4199/c00031ed1v01y201105isp019 · Cited by 224
Zhang, D. X., Mendoza, S. A., Bubolz, A. H., Mizuno, A., Ge, Z., Li, R., Warltier, D. C., Suzuki, M., & Gutterman, D. D. (2009) · Hypertension · doi:10.1161/hypertensionaha.108.127100 · Cited by 197
Transient receptor potential ( TRP ) channels in the airway: role in airway disease
Grace, M. S., Baxter, M. D., Dubuis, E. D., Birrell, M. A., & Belvisi, M. G. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12538 · Cited by 190
Mechanosensitive TRP channels in cardiovascular pathophysiology
Inoue, R., Zhong, J., & Kawarabayashi, Y. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.05.009 · Cited by 199
Role of TRP channels in the cardiovascular system
Yue, Z., Xie, J., Yu, A. S., Stock, J., Du, J., & Yue, L. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00457.2014 · Cited by 193
Veldhuis, N. A., Poole, D. P., Grace, M. S., McIntyre, P., & Bunnett, N. W. (2014) · Pharmacological Reviews · doi:10.1124/pr.114.009555 · Cited by 177
TRPV4 and the Regulation of Vascular Tone
Filosa, J. A., Yao, X., & Rath, G. (2012) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318279ba42 · Cited by 168
Transient receptor potential channelopathies
Nilius, B., & Owsianik, G. (2010) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-010-0788-2 · Cited by 168
García-Elías, A., Mrkonjić, S., Jung, C., Pardo-Pastor, C., Vicente, R., & Valverde, M. A. (2014) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-54215-2_12 · Cited by 163
TRPV4 Agonists and Antagonists
Vincent, F., & Duncton, M. A. J. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/156802611796904861 · Cited by 154
Ischemic Heart Disease and Heart Failure: Role of Coronary Ion Channels
Severino, P., D’Amato, A., Pucci, M., Infusino, F., Birtolo, L. I., Mariani, M. V., Lavalle, C., Maestrini, V., Mancone, M., & Fedele, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093167 · Cited by 167
Application of the Pentafluorosulfanyl Group as a Bioisosteric Replacement
Sowaileh, M. F., Hazlitt, R. A., & Colby, D. A. (2017) · ChemMedChem · doi:10.1002/cmdc.201700356 · Cited by 151
TRP channels: Emerging targets for respiratory disease
Banner, K. H., Igney, F. H., & Poll, C. T. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.03.005 · Cited by 138
TRPV4—A Missing Link Between Mechanosensation and Immunity
Michalick, L., & Kuebler, W. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00413 · Cited by 144
Negri, S., Faris, P. S., Berra‐Romani, R., Guerra, G., & Moccia, F. D. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2019.01618 · Cited by 132
Modulation of the TRPV4 ion channel as a therapeutic target for disease
Grace, M. S., Bonvini, S. J., Belvisi, M. G., & McIntyre, P. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.02.019 · Cited by 136
Astrocyte regulation of cerebral vascular tone
Filosa, J. A., & Iddings, J. A. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00359.2013 · Cited by 130
Update on vascular endothelial Ca2+signalling: A tale of ion channels, pumps and transporters
Moccia, F. D. (2012) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v3.i7.127 · Cited by 119
Arresting a Transient Receptor Potential (TRP) Channel
Shukla, A. K., Kim, J., Ahn, S., Xiao, K., Shenoy, S. K., Liedtke, W., & Lefkowitz, R. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.141549 · Cited by 111
Modulation of water efflux through functional interaction between TRPV4 and TMEM16A/anoctamin 1
Takayama, Y., Shibasaki, K., Suzuki, Y., Yamanaka, A., & Tominaga, M. (2014) · The FASEB Journal · doi:10.1096/fj.13-243436 · Cited by 113
Mihara, H., Boudaka, A., Sugiyama, T., Moriyama, Y., & Tominaga, M. (2011) · The Journal of Physiology · doi:10.1113/jphysiol.2011.207829 · Cited by 112
Bao, W., Aravindhan, K., Alsaid, H., Chendrimada, T. P., Szapacs, M. E., Citerone, D. R., Harpel, M. R., Willette, R. N., Lepore, J. J., & Jucker, B. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023570 · Cited by 106
Self-citationAdapala, R. K., Talasila, P. K., Bratz, I. N., Zhang, D. X., Suzuki, M., Meszaros, J. G., & Thodeti, C. K. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00142.2011 · Cited by 101
Vascular TRP Channels: Performing Under Pressure and Going with the Flow
Hill‐Eubanks, D. C., Gonzales, A. L., Sonkusare, S. K., & Nelson, M. T. (2014) · Physiology · doi:10.1152/physiol.00009.2014 · Cited by 103
Cheung, M., Bao, W., Behm, D. J., Brooks, C. A., Bury, M. J., Dowdell, S. E., Eidam, H. S., Fox, R. M., Goodman, K. B., Holt, D. A., et al. (2017) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.7b00094 · Cited by 99
Self-citationEndothelium-Dependent Hyperpolarization and Endothelial Dysfunction
Félétou, M. (2015) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000346 · Cited by 98
Determinants of TRPV4 Activity following Selective Activation by Small Molecule Agonist GSK1016790A
Jin, M., Wu, Z., Chen, L., Jaimes, J., Collins, D., Walters, E. T., & O’Neil, R. G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016713 · Cited by 100
Gradilone, S. A., Masyuk, T. V., Huang, B. Q., Bañales, J. M., Lehmann, G. L., Radtke, B. N., Stroope, A. J., Masyuk, A. I., Splinter, P. L., & LaRusso, N. F. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.04.010 · Cited by 94
Baxter, M. D., Eltom, S. M., Dekkak, B., Yew‐Booth, L., Dubuis, E. D., Maher, S. A., Belvisi, M. G., & Birrell, M. A. (2014) · Thorax · doi:10.1136/thoraxjnl-2014-205467 · Cited by 95
Zhang, L., Papadopoulos, P., & Hamel, É. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12315 · Cited by 94
Phuong, T. T. T., Redmon, S. N., Yarishkin, O., Winter, J. M., Li, D. Y., & Križaj, D. (2017) · The Journal of Physiology · doi:10.1113/jp275052 · Cited by 91
Facilitation of TRPV4 by TRPV1 is required for itch transmission in some sensory neuron populations
Kim, S., Barry, D. M., Liu, X., Yin, S., Munanairi, A., Meng, Q.-T., Cheng, W., Ping, M., Wan, L., Liu, S.-B., et al. (2016) · Science Signaling · doi:10.1126/scisignal.aaf1047 · Cited by 90
Modulation of TRPV4 by diverse mechanisms
Darby, W. G., Grace, M. S., Baratchi, S., & McIntyre, P. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.07.012 · Cited by 90
Calcium signalling and breast cancer
So, C. L., Saunus, J. M., Roberts‐Thomson, S. J., & Monteith, G. R. (2018) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2018.11.001 · Cited by 91
Vascular KCa-channels as therapeutic targets in hypertension and restenosis disease
Köhler, R., Kaistha, B. P., & Wulff, H. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220903540257 · Cited by 85
Oncosis and apoptosis induction by activation of an overexpressed ion channel in breast cancer cells
Peters, A. A., Jamaludin, S. Y. N., Yapa, K. T. D. S., Chalmers, S., Wiegmans, A. P., Lim, H. F., Milevskiy, M. J. G., Azimi, I., Davis, F. M., Northwood, K. S., et al. (2017) · Oncogene · doi:10.1038/onc.2017.234 · Cited by 85
Zhang, D. X., & Gutterman, D. D. (2010) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3181fd35d1 · Cited by 82
Sukumaran, S. V., Singh, T. U., Parida, S., Reddy, C. E. N., Thangamalai, R., Kandasamy, K., Singh, V., & Mishra, S. K. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2013.09.005 · Cited by 81
Role of MMP2 and MMP9 in TRPV4-induced lung injury
Villalta, P. C., Ročić, P., & Townsley, M. I. (2014) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00113.2014 · Cited by 80
Jones, J. L., Peana, D., Veteto, A. B., Lambert, M. D., Nourian, Z., Karasseva, N. G., Hill, M. A., Lindman, B. R., Baines, C. P., Krenz, M., et al. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy156 · Cited by 80
Earley, S. (2010) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3181f580d9 · Cited by 79
TRPV4 Dysfunction Promotes Renal Cystogenesis in Autosomal Recessive Polycystic Kidney Disease
Zaika, O., Mamenko, M., Berrout, J., Boukelmoune, N., O’Neil, R. G., & Pochynyuk, O. M. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012050442 · Cited by 77
Transient Receptor Potential Channels and Endothelial Cell Calcium Signaling
Thakore, P., & Earley, S. (2019) · Comprehensive physiology · doi:10.1002/cphy.c180034 · Cited by 95
Klausen, T. K., Pagani, A., Minassi, A., Ech‐Chahad, A., Prenen, J., Owsianik, G., Hoffmann, E. K., Pedersen, S. F., Appendino, G., & Nilius, B. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm9001007 · Cited by 74
Kuebler, W. M., Jordt, S., & Liedtke, W. (2020) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00161.2020 · Cited by 74
Ji, C., & McCulloch, C. A. (2020) · FEBS Journal · doi:10.1111/febs.15665 · Cited by 78
TRPV4: physiological role and therapeutic potential in respiratory diseases
Goldenberg, N. M., Ravindran, K., & Kuebler, W. M. (2014) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-014-1058-1 · Cited by 76
Seki, T., Gotō, K., Kiyohara, K., Kansui, Y., Murakami, N., Haga, Y., Ohtsubo, T., Matsumura, K., & Kitazono, T. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.07110 · Cited by 72
Effects of TRPV4 cation channel activation on the primary bladder afferent activities of the rat
Aizawa, N., Wyndaele, J., Homma, Y., & Igawa, Y. (2011) · Neurourology and Urodynamics · doi:10.1002/nau.21212 · Cited by 71
Role of Transient Receptor Potential Vanilloid 4 in Vascular Function
Liu, L., Guo, M., Lv, X., Wang, Z., Yang, J., Li, Y., Yu, F., Wen, X., Feng, L., & Zhou, T. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.677661 · Cited by 70
Dalsgaard, T., Sonkusare, S. K., Teuscher, C., Poynter, M. E., & Nelson, M. T. (2016) · Scientific Reports · doi:10.1038/srep33841 · Cited by 69
Monaghan, K. P., McNaughten, J., McGahon, M. K., Kelly, C., Kyle, D., Yong, P. H., McGeown, J. G., & Curtis, T. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128359 · Cited by 69
Woolums, B. M., McCray, B. A., Sung, H., Tabuchi, M., Sullivan, J. M., Takle, K. A., Yang, Y., Mamah, C., Aisenberg, W. H., Saavedra-Rivera, P. C., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16411-5 · Cited by 68
A novel TRPV4-specific agonist inhibits monocyte adhesion and atherosclerosis
Xu, S., Liu, B., Yin, M., Королева, М. В., Mastrangelo, M. A., Ture, S. K., Morrell, C. N., Zhang, D. X., Fisher, E. A. A., & Jin, Z. G. (2016) · Oncotarget · doi:10.18632/oncotarget.9376 · Cited by 68
Toft‐Bertelsen, T. L., Križaj, D., & MacAulay, N. (2017) · The Journal of Physiology · doi:10.1113/jp274135 · Cited by 68
Calcium signals that determine vascular resistance
Ottolini, M., Hong, K., & Sonkusare, S. K. (2019) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1448 · Cited by 70
Emerging concepts for the role of TRP channels in the cardiovascular system
Vennekens, R. (2010) · The Journal of Physiology · doi:10.1113/jphysiol.2010.202077 · Cited by 61
Vanilloid and Melastatin Transient Receptor Potential Channels in Vascular Smooth Muscle
Earley, S. (2010) · Microcirculation · doi:10.1111/j.1549-8719.2010.00026.x · Cited by 60
Dong, Q., Li, J., Wu, Q., Zhao, N., Qian, C., Ding, D., Wang, B., Chen, L., Guo, K., Fu, D., et al. (2017) · Scientific Reports · doi:10.1038/srep42678 · Cited by 63
Recent advances in TRPV4 agonists and antagonists
Lawhorn, B. G., Brnardic, E. J., & Behm, D. J. (2020) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2020.127022 · Cited by 61
Self-citationBrooks, C. A., Barton, L. S., Behm, D. J., Eidam, H. S., Fox, R. M., Hammond, M., Hoang, T. H., Holt, D. A., Hilfiker, M. A., Lawhorn, B. G., et al. (2019) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.9b00274 · Cited by 59
Self-citationNociceptive and pro‐inflammatory effects of dimethylallyl pyrophosphate via TRPV4 activation
Bang, S., Yoo, S., Yang, T., Cho, H., & Hwang, S. W. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01884.x · Cited by 59
McAlexander, M. A., Luttmann, M. A., Hunsberger, G. E., & Undem, B. J. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.210203 · Cited by 59
Aravindhan, K., Bao, W., Harpel, M. R., Willette, R. N., Lepore, J. J., & Jucker, B. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130894 · Cited by 61
Self-citationBeyond Hot and Spicy: TRPV Channels and their Pharmacological Modulation
Seebohm, G., & Schreiber, J. A. (2021) · Cellular Physiology and Biochemistry · doi:10.33594/000000358 · Cited by 56
TRPV4 Mechanotransduction in Fibrosis
Adapala, R. K., Katari, V., Teegala, L. R., Thodeti, S., Paruchuri, S. M., & Thodeti, C. K. (2021) · Cells · doi:10.3390/cells10113053 · Cited by 59
Kumar, H., Lim, C. S., Choi, H., Joshi, H. P., Kim, K., Kim, Y. H., Park, C., Kim, H. M., & Han, I. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.2035-19.2020 · Cited by 57
GPCR ‐mediated EGF receptor transactivation regulates TRPV 4 action in the vasculature
Saifeddine, M., El‐Daly, M., Mihara, K., Bunnett, N. W., McIntyre, P., Altier, C., Hollenberg, M. D., & Ramachandran, R. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13072 · Cited by 53
Modulators of Transient Receptor Potential (TRP) Channels as Therapeutic Options in Lung Disease
Dietrich, A. (2019) · Pharmaceuticals · doi:10.3390/ph12010023 · Cited by 54
Genovese, M., Borrelli, A., Venturini, A., Guidone, D., Caci, E., Viscido, G., Gambardella, G., di Bernardo, D., Scudieri, P., & Galietta, L. J. V. (2019) · The Journal of Physiology · doi:10.1113/jp278784 · Cited by 55
Matsumoto, K., Yamaba, R., Inoue, K., Utsumi, D., Tsukahara, T., Amagase, K., Tominaga, M., & Kato, S. (2017) · British Journal of Pharmacology · doi:10.1111/bph.14072 · Cited by 52
Rapid Assessment of Nanoparticle Extravasation in a Microfluidic Tumor Model
Vu, M. N., Rajasekhar, P., Poole, D. P., Khor, S. Y., Truong, N. P., Nowell, C. J., Quinn, J. F., Whittaker, M., Veldhuis, N. A., & Davis, T. P. (2019) · ACS Applied Nano Materials · doi:10.1021/acsanm.8b02056 · Cited by 52
Dragoni, S., Guerra, G., Fiorio, A., Bertoni, G., Rappa, A., Poletto, V., Bottino, C., Aronica, A., Lodola, F., Cinelli, M. P., et al. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24686 · Cited by 51
Narita, K., Sasamoto, S., Koizumi, S., Okazaki, S., Nakamura, H., Inoue, T., & Takeda, S. (2015) · The FASEB Journal · doi:10.1096/fj.14-261396 · Cited by 50
TRPV4: a Sensor for Homeostasis and Pathological Events in the CNS
Kumar, H., Lee, S., Kim, K., Zeng, X., & Han, I. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0998-8 · Cited by 50
Deruyver, Y., Weyne, E., Dewulf, K., Rietjens, R., Pinto, S., Ranst, N. V., Franken, J., Vanneste, M., Albersen, M., Gevaert, T., et al. (2018) · European Urology · doi:10.1016/j.eururo.2018.05.020 · Cited by 50
Transient receptor potential vanilloid 1 ( TRPV 1), TRPV 4, and the kidney
Kaßmann, M., Harteneck, C., Zhu, Z., Nürnberg, B., Tepel, M., & Gollasch, M. (2012) · Acta Physiologica · doi:10.1111/apha.12051 · Cited by 49
Oliván‐Viguera, A., García-Otín, A. L., Lozano-Gerona, J., Lachén, E. A., García‐Malinis, A. J., Hamilton, K. L., Gilaberte, Y., Pueyo, E., & Köhler, R. (2018) · PLoS ONE · doi:10.1371/journal.pone.0190307 · Cited by 51
Nayak, P. S., Wang, Y., Najrana, T., Priolo, L., Rios, M., Shaw, S. K., & Sanchez‐Esteban, J. (2015) · Respiratory Research · doi:10.1186/s12931-015-0224-4 · Cited by 48
Metadata
- Authors
- Willette, R. N., Bao, W., Nerurkar, S., Yue, T.-L., Doe, C. P., Stankus, G., Turner, G. H., Ju, H., Thomas, H., Fishman, C. E., Sulpizio, A., Behm, D. J., Hoffman, S., Lin, Z., Lozinskaya, I., Casillas, L. N., Lin, M., Lee Trout, R. E., Votta, B. J., Thorneloe, K., Lashinger, E. S. R., Figueroa, D. J., Marquis, R., & Xu, X.
- Affiliations
- GlaxoSmithKline (United States) (US)
- ORCID
- Venue
- The Journal of Pharmacology and Experimental Therapeutics
- Publisher
- Elsevier BV
- Published
- 2008-08
- Volume
- 326
- Issue
- 2
- Pages
- 443-452
- ISSN
- 0022-3565 (ISSN-L)
- OpenAlex
- W2161804336
- Cited by
- 300
- References
- 21
- Citations by year
- 2026: 12 · 2025: 8 · 2024: 8 · 2023: 20 · 2022: 16 · 2021: 14 · 2020: 24 · 2019: 21 · 2018: 16 · 2017: 22 · 2016: 17 · 2015: 19 · 2014: 22 · 2013: 14 · 2012: 20
- FWCI
- 7.46
- Type
- journal article
- Language
- en
- Update notices
- erratum (2011-07-01)
- Open access
- closed
- Locations
- Journal of Pharmacology and Experimental Therapeutics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Sensory Systems › Ion Channels and Receptors
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Calcium signaling and nucleotide metabolism
- Keywords
- TRPV4, GSK1016790A, cardiovascular collapse, endothelial permeability, endothelial injury, endothelial cell retraction, nitric oxide synthase, endothelium-dependent relaxation, blood pressure reduction, cardiac output, TRPV4 knockout mice, edema
- MeSH terms
- Animals, Aorta, Thoracic, Capillary Permeability, Cell Adhesion, Cell Line, Dogs, Dose-Response Relationship, Drug, Endothelium, Vascular, Female, Hemodynamics, Humans, Immunohistochemistry, Leucine, Male, Sulfonamides, Vasoconstriction, Molecular Structure, Ventricular Function, Left, Rats, Sprague-Dawley, Mice, Knockout, Patch-Clamp Techniques, TRPV Cation Channels, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review